Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Rheumatoid arthritis is an autoimmune disease that exhibits significant clinical heterogeneity. There are various treatments for rheumatoid arthritis, including disease-modifying anti-rheumatic drugs (DMARDs), glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs), and inflammatory cytokine...
Guardado en:
Autores principales: | Jianan Zhao, Shicheng Guo, Steven J. Schrodi, Dongyi He |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d9be0209f0246b68da5a479a432aaf9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HETEROGENEITY OF POLYCLONAL IMMUNOGLOBULINS NUCLEASE ACTIVITY IN RHEUMATOID AND REACTIVE ARTHRITIS
por: M. V. Volkova, et al.
Publicado: (2017) -
Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021) -
Evaluation of the Health Assessment Questionnaire Disability Index in Chilean patients with rheumatoid arthritis
por: Durán,Josefina, et al.
Publicado: (2019) -
Functional implications of B lymphocytes in the development of rheumatoid arthritis
por: Juan-Manuel Anaya, et al.
Publicado: (2006) -
Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland
por: Wiktor Schmidt, et al.
Publicado: (2020)